ESTERASE-ACTIVITY TOWARD THE DIASTEREOMERS OF CEFUROXIME AXETIL IN THE RAT AND DOG

被引：15

作者：

MOSHER, GL

MCBEE, J

SHAW, DB

机构：

[1] Eli Lilly and Co., Drop 6414, Lilly Corporate Center, Indianapolis

来源：

PHARMACEUTICAL RESEARCH | 1992年 / 9卷 / 05期

关键词：

CEFUROXIME AXETIL; ESTERASE; SPECIES DIFFERENCES; DIASTEREOMERS; STEREOSELECTIVE HYDROLYSIS;

D O I：

10.1023/A:1015818614282

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：687 / 689

页数：3

共 13 条

[1] SUBSTRATE SPECIFICITY AND TOXICOLOGICAL SIGNIFICANCE OF PYRETHYROID-HYDROLYZING ESTERASES OF MOUSE LIVER-MICROSOMES [J].

ABERNATHY, CO ;

UEDA, K ;

ENGEL, JL ;

GAUGHAN, LC ;

CASIDA, JE .

PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 1973, 3 (03) :300-311

[2] PURIFICATION AND PARTIAL CHARACTERIZATION OF RAT INTESTINAL CEFUROXIME AXETIL ESTERASE [J].

CAMPBELL, CJ ;

CHANTRELL, LJ ;

EASTMOND, R .

BIOCHEMICAL PHARMACOLOGY, 1987, 36 (14) :2317-2324

[3] ENANTIOSELECTIVE HYDROLYSIS OF 2-(CHLOROPHENOXY)PROPIONIC ESTERS BY ESTERASES [J].

DERNONCOUR, R ;

AZERAD, R .

TETRAHEDRON LETTERS, 1987, 28 (40) :4661-4664

[4] EFFECT OF DOSE AND FOOD ON THE BIOAVAILABILITY OF CEFUROXIME AXETIL [J].

FINN, A ;

STRAUGHN, A ;

MEYER, M ;

CHUBB, J .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1987, 8 (06) :519-526

[5] CEFUROXIME - HUMAN PHARMACOKINETICS [J].

FOORD, RD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (05) :741-747

[6] PHARMACOLOGY OF CEFUROXIME AS THE 1-ACETOXYETHYL ESTER IN VOLUNTEERS [J].

HARDING, SM ;

WILLIAMS, PEO ;

AYRTON, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :78-82

[7] SPECIES-DIFFERENCE AND CHARACTERIZATION OF INTESTINAL ESTERASE ON THE HYDROLIZING ACTIVITY OF ESTER-TYPE DRUGS [J].

INOUE, M ;

MORIKAWA, M ;

TSUBOI, M ;

SUGIURA, M .

JAPANESE JOURNAL OF PHARMACOLOGY, 1979, 29 (01) :9-16

[8]

JENNER P, 1973, DRUG METAB REV, V2, P117

[9] STEREOSPECIFICITY OF ESTERASES HYDROLYZING OXAZEPAM ACETATE [J].

MAKSAY, G ;

TEGYEY, Z ;

OTVOS, L .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (09) :1208-1210

[10]

QUON CY, 1988, DRUG METAB DISPOS, V16, P425

← 1 2 →